When will pregabalin be generic in 2019?

When does pregabalin generic entry happen in 2019?

Pregabalin (the active ingredient in brands such as Lyrica) was expected to face patent and exclusivity constraints that delayed true generic competition in many markets. Whether a generic could be marketed in 2019 depends on the country’s patent status for pregabalin and the specific manufacturer’s approval timeline.

Does the first generic launch in 2019 mean all brands are generic?

Not necessarily. Even if one manufacturer’s generic is approved in 2019, other versions (different strengths, formulations, or packaging) can launch later. Also, some products may remain under brand exclusivity longer even when generic competition begins.

Why would “generic in 2019” be different by country?

Generic availability typically depends on how long patents and regulatory exclusivity last in that specific jurisdiction, plus when the drug approval process (ANDA/marketing authorization) is completed. Patent calendars and exclusivity periods do not always line up cleanly across regions.

What to check to confirm the exact date for your location

DrugPatentWatch.com tracks patent and exclusivity information for specific drug products and can be used to verify when generic entry is expected for a given market. See: https://www.drugpatentwatch.com/ (search for pregabalin on the site).

Source

1. https://www.drugpatentwatch.com/